Introduction
Inherited bone marrow failure syndromes (IBMFS) are disorders that include the inability to make normal numbers of all or specific types of blood cells (pancytopenia, or anemia, leukopenia, and thrombocytopenia). 1 Mutations in more than 40 genes associated with various IBMFS have been identified to date. 2 However, these genes are not specific for hematopoietic cells per se, because patients with IBMFS often have multi-organ manifestations. Dyskeratosis congenita (DC) is an IBMFS, which in its classic form is characterized by the triad of oral leukoplakia, nail dystrophy, and abnormal skin pigmentation, but also includes high rates of severe aplastic anemia (the main cause of death), pulmonary fibrosis, stenosis of the esophagus, urethra and/or lacrimal ducts, liver disease, premature graying of hair, and osteopenia. 2 Gene mutations in subunits of telomerase (DKC1, TERT, TERC, NOP10, NHP2), and in genes involved in telomere biology (WRAP53, TINF2, CTC1, RTEL1) are associated with DC, which can be inherited in an X-linked recessive, autosomal dominant or autosomal recessive fashion. [3] [4] [5] Furthermore, an appreciable minority of patients with apparent acquired aplastic anemia, but no stigmata of DC, have been found to have germline mutations in genes of the telomerase complex. 6, 7 Thus, patients with telomere biology disorders (which we collectively refer to as TBD in this study) present with a broad clinical spectrum ranging from a severe multi-organ phenotype as in DC, to one more limited to bone marrow aplasia.
Bone marrow failure (BMF) due to mutations in telomere biology-related genes is most likely related to improper telomere maintenance in hematopoietic stem cells For personal use only. on October 31, 2017. by guest www.bloodjournal.org From (HSCs), leading to limited proliferative potential. However, the ability of HSCs to maintain a normal balance between quiescence and proliferation, self-renewal and differentiation, is based not solely on their intrinsic properties, but also on the microenvironment in which they reside, the HSC niche, as proposed by Schofield. 8 As known from the work of Friedenstein and coworkers, adherent, non-hematopoietic cells of bone marrow (BM) stroma, bone marrow stromal cells, (BMSCs, also known as bone marrow-derived "mesenchymal stem cells") are able to re-create the hematopoietic microenvironment (HME) upon in vivo transplantation into mice. 9, 10 Subsequently, a subset of multipotent skeletal stem cells (SSCs) was identified within the BMSC population, capable of re-forming a bone/marrow organ (composed of bone, hematopoiesis-supportive stroma, marrow adipocytes of donor origin; hematopoiesis of recipient origin) upon in vivo transplantation. 11 Self-renewal of SSCs was also demonstrated, and their location was pinpointed to the subluminal side of marrow sinusoids (pericytes), where HSCs also reside. 12 Mature osteoblastic cells, 13 endothelial cells, 14 and BMSCs expressing CXCL12, 12, 15, 16 CD146, 12 Nestin, 17 LEPR, 18 and others (reviewed in Ugarte and Forsberg 19 ) have been suggested to be constituents of the hematopoietic "niche." In the quest for an identifiable "niche"-maintaining cell, current research is directed towards perivascular SSCs/BMSCs. 12, 16, 17, 20, 21 Understanding the biological properties of SSCs/BMSCs has important implications not only for skeletal physiology and disease, but also for understanding regulation of HSC physiology and dysregulation of hematopoiesis in blood disorders.
For personal use only. on October 31, 2017. by guest www.bloodjournal.org From Based on the central role that SSCs/BMSCs play in skeletal physiology, we previously hypothesized that mutations affecting their function would result in a skeletal disease. Proof of principle came from examination of fibrous dysplasia of bone (FD), caused by somatic missense activating mutations in the GNAS gene that codes for the G protein, Gsα. FD is characterized by replacement of normal lamellar bone and marrow with under-mineralized woven bone and fibrotic marrow devoid of hematopoiesis. 22 By using FD-BMSCs in an in vivo transplantation assay to form an ectopic ossicle, the same abnormalities seen in FD lesions were recapitulated, including a lack of hematopoiesis. 23 Consistent with their role in hematopoietic support, SSCs/BMSCs can also mediate the effects of mutations on hematopoiesis, contributing to establishment of hematopoietic disease phenotypes. For example, a myeloproliferative syndrome was generated in mice in which RARγ was specifically eliminated from the HME. 24 We also noted that SSCs/BMSCs from some IBMFS patients failed to re-establish the HME upon in vivo transplantation, whereas normal SSCs/BMSCs were routinely capable of doing so. 25 While BMSCs from a DC patient were reported to display morphological abnormalities, 26 direct assessment of SSC/BMSC function in TBD has not been reported. The purpose of this study was to characterize SSCs/BMSCs from patients with mutations in genes related to telomere maintenance and determine whether they contribute to BMF.
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Materials and methods

Bone marrow (BM) acquisition
BM was obtained from normal donors (N, n=13) under an IRB-approved protocol (NIDCR 94-D-0188, ClinicalTrials.gov NCT00001391), or from surgical waste (OHSR Assurance #3113), from patients with TBD (n=11, NCI 02-C-0052, 27 or NHLBI 97-H-0041, ClinicalTrials.gov NCT00027274 and NCT00001620, respectively), and from 3 mutation-free donors related to 2 TBD patients. For comparison, BM was obtained from patients with BMF not related to telomere biology [Shwachman-Diamond syndrome (SDS, n=4), Diamond-Blackfan anemia (DBA, n=4), and newly diagnosed acquired aplastic anemia patients (before treatment) without family histories or mutations in telomere-related genes (AAA, n=8)] under IRB-approved protocols (02-C-0052 and 97-H-0041). All participants or their guardians provided written informed consent in accordance with Health and Human Services regulation 45 CFR 46 and the Declaration of Helsinki. Patient characteristics, their mutations, and assays performed using their cells are shown in Table 1 .
Primary and secondary colony forming efficiency (CFE) assays
BM single-cell suspensions obtained from surgical waste or from bone fragments within the Jamshidi needle used for aspiration were used to establish cultures at clonal density (primary CFEs, 25 Supplementary Methods) to estimate the number of SSCs in bone 
Non-clonal BMSC cultures
BM single-cell suspensions were used to establish non-clonal BMSC cultures from normal donors (N-BMSCs) and from all patients (TBD-BMSCs, SDS-BMSCs, DBA-BMSCs and AAA-BMSCs) as described previously 25 (Supplementary Methods). 10 mM β-glycerophosphate was added to the growth medium [containing 10 -8 M dexamethasone and 10 -4 M ascorbic acid-2-phosphate (Dex/AscP)] for osteogenic differentiation. Cells were used between P2-P4.
In vitro colorimetric assays
Oil red O staining was used to demonstrate adipogenesis in vitro as described 
In vivo transplantation assay
BMSCs were attached to ceramic particles and transplanted subcutaneously into immunocompromised mice (2 transplants/normal or patient donors) to form an ectopic ossicle as previously described 29,30 (Supplementary Methods) under an institutionallyapproved animal study protocol. After 8wks, transplants were harvested and fixed for histological evaluation with a Nikon Optiphot-2 microscope (Garden City, NY) using a PlanApo 10/0.45 lens. Images were acquired with an Insight CCD camera and software (SPOT Imaging Solutions, Sterling Heights, MI).
TERC knockdown
To mimic the defect found in TBD-BMSCs, TERC expression was reduced in N-BMSCs in two different ways. Initially, TERC short hairpin (sh) RNA lentiviral particles were 
Cytokine secretion analysis
Cytokines in conditioned medium were analyzed using a RayBio® Human Cytokine Antibody Array 6 (60) according to the manufacturer's instructions (see Supplementary Materials for details).
Statistics
Statistical analyses were performed using Prism 6. Data are presented as the mean+standard deviation. Statistical significance is indicated when p<0.05. For microarray analysis, the Student's t-test (fold change >2, corrected p<0.05) was used.
Hierarchical clustering analyses were performed by clustering on cell type, using
Pearson-centered similarity measures and a centroid linkage rule.
Results
TBD-BMSC abnormalities in vitro
CFEs (estimates of stromal stem/progenitor cells capable of density-independent clonal growth, 31 ) were assessed in fresh BM single-cell suspensions from normal donors and TBD patients (n=9 each) by counting colonies established by single Colony Forming Units-Fibroblasts (CFU-Fs). For comparison, CFEs were also determined for SDS (n=4) and DBA (n=4) patients (fresh aspirates from AAA patients were unavailable). CFEs for normal donors were 12.0+1.2 colonies/100,000 BM-nucleated cells, comparable with previous reports. 32-36 Similar results were also found for SDS and DBA, and for a single fresh AAA aspirate previously analyzed (Supplementary Figure 1A) . While the range in TBD CFEs was broad, TBD cells formed only 3.6+5.2 colonies/100,000 cells, which is significantly lower than normal (p<0.0001, Figure 1A ).
In preliminary experiments, we noted that TBD-BMSCs grew very poorly in medium without Dex/AscP (data not shown). Subsequent cultures were established in medium with Dex/AscP to increase proliferation and the number of cells for experiments. 25 In secondary CFE assays at P1, the number of colonies increased in all samples compared with those in primary assays, due to the increased number of clonogenic, but transiently amplifying cells generated during culture that were not present in primary CFE assays. 37 However, even in the secondary assays, the CFEs of TBD-BMSCs were substantially lower than that of N-BMSCs, SDS-BMSCs, DBA-BMSCs and AAA-BMSCs ( Figure 1B) .
In non-clonal cultures, TBD-BMSCs exhibited properties markedly different from those of N-BMSCs. Unlike N-BMSCs (Figure 2A ), TBD-BMSCs underwent massive, spontaneous adipogenic differentiation, even when cultured under osteogenic conditions (9/11 TBD-BMSC cultures, Figure 2B ). The adipogenic predilection of TBD-BMSCs was supported by a high level of expression of PPARG (n=2 TBD patients) compared with N-BMSCs ( Figure 2C ). The remaining two TBD-BMSC cultures (from two related patients) focally deposited large amounts of collagenous matrix ( Figure 2D ). However, cells from three mutation-free siblings in this kindred also underwent fibrosis (data not shown). These clinically unaffected relatives exhibited a tendency for hypocellular marrow, and/or slightly shorter telomeres (see Table 1 ), presumably due to inheritance of short telomeres but not the disease-associated mutation. TBD-BMSCs from all other patients were far less fibrotic. Spontaneous adipogenic differentiation and massive fibrosis were never observed in N-BMSC cultures in basal or osteogenic differentiation medium, nor was it observed in AAA-BMSC cultures (Supplementary Figure 1B) . N-BMSCs and AAA-BMSCs maintained their fibroblastic morphology with continued passage (Figure 2E , Supplementary Figure 1B ), but TBD-BMSCs increasingly displayed a senescent morphology (very large and flat). By P4, they stopped growing, and never became confluent (all TBD-BMSCs) ( Figure 2F ). Premature senescence of TBD-BMSCs in comparison with N-BMSCs at P4 was evident by a highly increased expression of SA-β-galactosidase (n=2 N, 2 TBD patients) ( Figure 2G ,H).
TBD-BMSCs do not form bone or support hematopoiesis in vivo
For personal use only. on October 31, 2017. by guest www.bloodjournal.org From When transplanted with a scaffold in vivo into immunocompromised mice ( Figure 3A ), N-BMSCs (even from older donors), formed copious amounts of bone, hematopoiesissupportive stroma, and marrow adipocytes, all of donor origin ( Figure 3B ). Interestingly, AAA-BMSCs also formed a normal ossicle ( Figure 3C ), in spite of the fact that they were isolated from aplastic marrow ( Figure 3D ). On the other hand, TBD-BMSCs did not form bone and instead formed varying levels of fibrous tissue in association with the scaffold, and areas of varying sizes were filled with adipocytes ( Figure 3E ,F).
Hematopoiesis did not colonize the transplants (n=8 TBD patients in duplicate). These in vivo results confirmed the results found in vitro: massive adipogenesis and fibrosis (in some instances) by TBD-BMSCs. Furthermore, TBD-BMSC-generated transplants reflect not only a skeletal aspect of TBD (osteopenia, avascular necrosis of the hip, fracture), but also the marrow aplasia as in native TBD marrow ( Figure 3G ).
TERC knockdown in N-BMSCs mimics the TBD-BMSC phenotype in vitro
Knockdown of TERC (a gene mutated in some of our patients) was used to determine if a reduction in TERC was able to establish a TBD-like phenotype in N-BMSCs. Attempts to create BMSC lines stably-deficient in TERC through the use of shRNA were unsuccessful due to the lack of cell proliferation (data not shown). Consequently, a siRNA approach was pursued. While there was a significant increase in TERC mRNA levels in transfection control (siNC) BMSCs compared with N-BMSCs, TERC was significantly reduced by siTERC-RNA compared with both N-BMSCs and siNC-BMSCs ( Figure 4A ).
When siTERC-BMSCs were replated 72 hours after treatment and allowed to proliferate for 7 days, a dramatic decrease was noted ( Figure 4B ). When the cells were replated for a secondary CFE assay, the CFE of siTERC-BMSCs was also significantly reduced ( Figure 4C ), while the CFE of siNC-BMSCs remained normal (compare with N-BMSCs in Figure 1B ). After replating, a large increase in the number of senescent cells in siTERC-BMSCs was noted in comparison with siNC-BMSCs ( Figure 4D ). While it would be desirable to use siTERC-BMSCs for the in vivo transplantation assay, this was not feasible due to the transient nature of siRNA inhibition (ectopic ossicles take 4-8 weeks to become established). Nonetheless, these results indicate that even transient TERC deficiency induces N-BMSCs to behave similar to TBD-BMSCs in vitro.
Transient TERC knockdown rapidly alters gene expression in N-BMSCs
Sufficient numbers of TBD-BMSCs could not be obtained for microarray analysis due to poor proliferation and early senescence. Therefore, siTERC-BMSCs were used as a model based on their similarity to TBD-BMSCs as described above. Microarray analysis was performed on RNA extracted after 72 hours of treatment from N-BMSCs, siNC-BMSCs and siTERC-BMSCs. The global gene expression showed a distinct pattern of under/over-represented genes in the siTERC-BMSCs, compared with siNC-BMSCs and N-BMSCs, which clustered together ( Figure 5A ). Analysis of genes that were altered more than 4-fold revealed a decrease in expression of CXCL12 (SDF-1, STROMAL-DERIVED FACTOR 1) ( Figure 5B ), a BMSC-derived chemokine related to migration of HSCs, 38 and regarded as a marker of "niche"-maintaining stromal cells. In further For personal use only. on October 31, 2017. by guest www.bloodjournal.org From analysis of genes that were altered by 2-fold ( Supplementary Table 1 ), ANGIOPOIETIN 1, known to play an important role in maintenance of the HSC niche, 12, 39 was significantly under-represented, as were other factors such as HEPATOCYTE GROWTH FACTOR and IL-6. KITL (KIT LIGAND, STEM CELL FACTOR) was also significantly altered, but by less than 2-fold ( Figure 5C ). Consistent with the osteogenic defect noted in TBD-BMSCs upon in vivo transplantation, the Wnt inhibitor, DKK1, was significantly over-represented ( Figure 5C ), while WISP1, a positive regulator of Wnt signaling, was significantly under-represented (Supplementary Table 1 ). Other members of the Wnt signaling pathway were altered ( Supplementary Figure 2) , as were lipoprotein biosynthetic pathways and membrane lipid biosynthetic processes ( Supplementary   Figures 3 and 4 ). However, after 72 hours of TERC knockdown, PPARG was not significantly altered (data not shown), unlike up-regulation noted in TBD-BMSCs. 
Discussion
In this study, we demonstrated that TBD-BMSCs display profound differences compared with N-BMSCs. In vitro, TBD-BMSCs had decreased CFE, indicating a reduced frequency of clonogenic SSCs/BMSCs, as has been found in TERC-deficient mice. 40, 41 Decreased CFE was also reflected by poor proliferation of TBD-BMSCs, along with accelerated senescence, which has also been described in TERC-deficient mice. 40, 41 Furthermore, TBD-BMSCs exhibited changes in differentiation potential, reflected by their spontaneous differentiation into adipocytes, and in some cases, collagen-depositing fibroblasts (two patients from one kindred), both in vitro and in vivo. However, fibrosis was noted in cells from mutation-free siblings in that kindred, therefore we cannot rule out a non-TBD cause, but we report the findings here based on the fact that many patients with TBD exhibit pulmonary and liver fibrosis. Transplantation of TBD-BMSCs resulted in development of "non-ossicles," comprised of fibrotic tissue, no bone, extensive areas of adipocytes, and devoid of hematopoiesis. The overall histology of these transplants mirrored directly, on the one hand, the spontaneous adipogenesis and fibrosis seen in TBD-BMSC cultures, and on the other, acellular fatty marrow as seen in bone biopsies from TBD patients. Interestingly, AAA-BMSCs from patients with non-familial acquired aplastic anemia were indistinguishable from N-BMSCs in their ability to grow and establish a complete bone/marrow organ. They did not reproduce the native aplastic marrow histology, reflecting the bystander role of stroma in which an immune attack of hematopoietic cells and progenitors leaves the function of stromal cells unscathed. 42 While it is possible that the abnormalities seen in TBD-BMSCs resulted from lack of For personal use only. on October 31, 2017. by guest www.bloodjournal.org From normal signals from hematopoietic cells in the abnormal marrow, these results strongly suggest that the defect noted in TBD-BMSCs is intrinsic to the cells themselves.
Reduced proliferation observed in TBD-BMSCs was directly mimicked by TERC knockdown in N-BMSCs, suggesting that the inherent phenotype of TBD-BMSCs with telomerase mutations was not only consistent with, but actually dependent on, their reduced telomerase activity. TERC knockdown in N-BMSCs induced profound changes in the expression of genes implicated in HME/niche function, such as CXCL12 and ANGIOPOIETIN-1. Likewise, DKK1 overexpression, implicated in induction of adipogenesis in BMSCs, was observed in siTERC-BMSCs, and PPARG overexpression in TBD-BMSCs, suggesting that induction of spontaneous adipogenesis can in turn be linked to reduced telomerase activity.
Altogether, these data establish a link between telomere maintenance in SSCs/BMSCs and their ability to differentiate into diverse stromal "lineages" such as osteoblasts, adipocytes or fibroblasts. Reduced telomere maintenance leads to reduced frequency of clonogenic progenitors (most likely due to their inability to self-renew as recently demonstrated in induced pluripotent stem cells derived from DC patients 43 ), and reduced proliferation and premature senescence of non-clonal populations. It also appears to abate their osteogenic capacity and to promote their adipogenic and fibrogenic capacity as assayed by in vivo transplantation. The inherent ability of SSCs/BMSCs to generate distinct lineages that belong to the natural bone/marrow organ is thus, in a way, synchronized with their growth history, inasmuch as senescence selects differentiation into certain lineages over others. The appearance of distinct stromal lineages (osteogenic and adipogenic) at distinct developmental times in individual skeletal segments is well For personal use only. on October 31, 2017. by guest www.bloodjournal.org From known, 44 and it was suggested previously that the distinct stromal lineages (osteogenic and adipogenic) are better conceptualized as distinct differentiation capacities acquired by a common stromal progenitor along a temporal sequence, rather than as an array of differentiation pathways that can be simultaneously elicited upon exposure to distinct signals/cues. 45 Importantly, our data link the replicative properties of SSCs/BMSCs with their ability to establish the HME in vivo. Recreation of the HME by SSCs/BMSCs in vivo was shown to be dependent upon establishment of sinusoids and self-renewal of transplanted cells into sinusoid-associated CD146-expressing stromal cells. 12 This provides a plausible connection between decreased proliferation and inability to transfer the HME, which our data support. TBD-BMSCs with impaired telomere maintenance and decreased proliferation fail to transfer the HME, bolstering the view that the ability of SSCs to self-renew is linked to their ability to host and retain hematopoiesis and HSCs. conditions, adipocytes may behave as negative regulators of hematopoiesis, 46 
leading to
For personal use only. on October 31, 2017. by guest www.bloodjournal.org From an inverse relationship between adipocyte content and hematopoietic cell mass at specific skeletal sites. Even in acquired aplastic anemia without telomere-related defects, adipocytes fill the void produced following hematopoietic destruction. 47 We have shown that senescence induced by TERC knockdown involves changes in expression of genes However, based on a population doubling time between 40-80 hours for N-BMSCs, [48] [49] [50] the changes noted in siTERC-BMSCs cannot be attributed to poor telomere maintenance, but must stem from a decrease in telomerase activity due to reduced TERC expression.
Evidence is emerging for a role of telomerase activity in stem cell biology that does not involve its role in telomere maintenance; 51 e.g., telomerase appears to modulate the Wntβ -catenin signaling pathway in epidermal stem cells. 52 To date, virtually all studies on non-telomeric functions of telomerase have focused on TERT, which has been identified as a transcriptional regulator of a number of genes. 51 However, TERT expression was unaltered by TERC knockdown in our study, and in TERC-null mice. 53 TERC may also have non-telomeric effects, based on changes observed after only 72hrs of TERC knockdown, and as suggested by profound defects in hematopoietic differentiation of induced pluripotent stem cells derived from patients with TERC mutations, independent of telomere length. 54 For personal use only. on October 31, 2017. by guest www.bloodjournal.org From
The strengths of our study lie in the ability to interrogate the function of TBD-SSCs/BMSCs in vitro, but more importantly, by in vivo transplantation, whereby the ability of the cells to support hematopoiesis was directly assessed. Furthermore, we were able to recapitulate a number of TBD-like changes in N-BMSCs by TERC knock-down, allowing us to begin to assess how TERC deficiency modulates SSC/BMSC function, particularly by analysis of factors that support hematopoiesis, adipogenesis and osteogenesis. The limitations of our study are based on the fact that our TBD patients are heterogeneous in age and mutations, and the limited number of patients with the same genotype precluded a stringent genotype/phenotype correlation. In addition, due to their low frequency in bone marrow, BMSCs were ex vivo-expanded to perform the study, which may lead to in vitro proliferative stress in TBD-BMSCs. However, such stress may also be clinically relevant in consideration of growth and maintenance of marrow in vivo.
In conclusion, our study shows that SSCs/BMSCs, responsible for the creation of the HME, may contribute (along with the defect in HSCs) to the TBD phenotype and BMF. This may also account for the lack of early engraftment, or BMF years later, noted in some TBD patients following allogeneic BM transplantation. 55 The notion that BMSCs may be involved in certain genetic hematological disorders is not new, as exemplified by the classically known hematological defects in Steel Factor (Kit Ligand, Stem Cell Factor)-deficient mice. 56 However, the defect in those mice could not be pinpointed to SSCs/BMSCs directly, based on Steel Factor expression by other cell types, 57 an issue averted by our transplantation assay. Our study highlights the role of the specific experimental layout provided by heterotopic transplantation of SSCs/BMSCs for dissecting intrinsic dysfunction of their hematopoiesis-supportive function. Our data also strengthen the emerging view that SSCs/BMSCs may represent targets of therapeutic intervention in specific hematological disorders emanating from an altered interplay between hematopoietic and stromal progenitors. Supplementary   Table 1 ), indicates a reduction in genes associated with hematopoiesis (again, CXCL12, and also ANGIOPOIETIN 1, HEPATOCYTE GROWTH FACTOR and IL6. KIT LIGAND (SCF) was also statistically lower in T cells than N and NC cells, although there was less than a 2-fold difference. The negative regulator of For personal use only. on October 31, 2017. by guest www.bloodjournal.org From the Wnt, DKK1, was statistically higher in T cells than in N and NC cells (*p<0.05). (B) A number of cytokines associated with hematopoiesis such as SCF, SDF-1, ANGIOGENIN and IL6 were found to be decreased between 18-30% in siTERC-BMSCs compared with siNC-BMSCs, although changes in SCF and SDF-1 were not significant when compared to N-BMSCs (*p<0.05).
